1. Mutti A, De Palma G, Goldoni M. Nuove prospettive nel monitoraggio biologico degli elementi metallici: l’esempio del cromo esavalente [New perspectives in biomonitoring of metallic elements: the example of hexavalent chromium, in Italian]. G Ital Med Lav Ergon 2012;34:51-4. PMID: 23213798Search in Google Scholar

2. Scarselli A, Binazzi A, Marzio DD, Marinaccio A, Iavicoli S. Hexavalent chromium compounds in the workplace: assessing the extent and magnitude of occupational exposure in Italy. J Occup Environ Hyg 2012;9:398-407. doi: 10.10 80/15459624.2012.68221610.1080/15459624.2012.68221622577838Search in Google Scholar

3. Myers JM, Antholine WE, Myers CR. Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells. Toxicology 2008;246:222-33. doi: 10.1016/ j.tox.2008.01.01710.1016/j.tox.2008.01.017238699818328613Search in Google Scholar

4. Nickens KP, Patierno SR, Ceryak S. Chromium genotoxicity: A double-edged sword. Chem Biol Interact 2010;188:276-88. doi: 10.1016/j.cbi.2010.04.01810.1016/j.cbi.2010.04.018294295520430016Search in Google Scholar

5. Yoshida M, Hatakeyama E, Hosomi R, Kanda S, Nishiyama T, Fukunaga K. Tissue accumulation and urinary excretion of chromium in rats fed diets containing graded levels of chromium chloride or chromium picolinate. J Toxicol Sci 2010;35:485-91. PMID: 2068633510.2131/jts.35.48520686335Search in Google Scholar

6. Zhitkovich A, Quievryn G, Messer J, Motylevich Z. Reductive activation with cysteine represents a chromium(III)- dependent pathway in the induction of genotoxicity by carcinogenic chromium(VI). Environ Health Perspect 2002;110(Suppl 5):729-31. PMID: 1242612110.1289/ehp.02110s5729124123412426121Search in Google Scholar

7. Wise SS, Holmes AL, Wise JP Sr. Hexavalent chromiuminduced DNA damage and repair mechanisms. Rev Environ Health 2008;23:39-57. doi: 10.1515/REVEH.2008.23.1.3910.1515/REVEH.2008.23.1.39Search in Google Scholar

8. Patlolla AK, Barnes C, Yedjou C, Velma VR, Tchounwou PB. Oxidative stress, DNA damage, and antioxidant enzyme activity induced by hexavalent chromium in Sprague-Dawley rats. Environ Toxicol 2009;24:66-73. doi: 10.1002/ tox.2039510.1002/tox.20395276956018508361Search in Google Scholar

9. Thompson CM, Fedorov Y, Brown DD, Suh M, Proctor DM, Kuriakose L, Haws LC, Harris MA. Assessment of CrVIinduced cytotoxicity and genotoxicity using high content analysis. PLoS One 2012;7:e42720. doi: 10.1371/journal. pone.0042720Search in Google Scholar

10. Costa AN, Moreno V, Prieto MJ, Urbano AM, Alpoim MC. Induction of morphological changes in BEAS-2B human bronchial epithelial cells following chronic sub-cytotoxic and mildly cytotoxic hexavalent chromium exposures. Mol Carcinog 2010;49:582-91. doi: 10.1002/mc.2062410.1002/mc.2062420336777Search in Google Scholar

11. Ernst E, Bonde JP. Sex hormones and epididymal sperm parameters in rats following sub-chronic treatment with hexavalent chromium. Human Exp. Toxicol. 1992; 11:255-258. PIMD: 135497210.1177/0960327192011004031354972Search in Google Scholar

12. Reitman S, Frankel S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol 1957;28:56-63. PMID: 1345812510.1093/ajcp/28.1.5613458125Search in Google Scholar

13. Karmen A, Wroblewski F, Ladue JS. Transaminase activity in human blood. J Clin Invest 1955;34:126-31. doi: 10.1172/ JCI10305510.1172/JCI103055Search in Google Scholar

14. Lowry OH, Rosebrough MJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75. PMID: 1490771310.1016/S0021-9258(19)52451-6Search in Google Scholar

15. Liu W, Chaspoul F, Botta C, De Meo M, Gallice P. Bioenergetics and DNA alteration of normal human fibroblasts by hexavalent chromium. Environ Toxicol Pharmacol 2010;29:58-63. doi: 10.1016/j.etap.2009.10.00110.1016/j.etap.2009.10.001Search in Google Scholar

16. Myers CR, Antholine WE, Myers JM. The pro-oxidant chromium(VI) inhibits mitochondrial complex I, complex II, and aconitase in the bronchial epithelium: EPR markers for Fe-S proteins. Free Radic Biol Med 2010;49:1903-15. doi: 10.1016/j.freeradbiomed.2010.09.02010.1016/j.freeradbiomed.2010.09.020Search in Google Scholar

17. Bagchi D, Stohs SJ, Downs BW, Bagchi M, Preuss HG. Cytotoxicity and oxidative mechanisms of different forms of chromium. Toxicology 2002;180:5-22. doi: 10.1016/ S0300-483X(02)00378-510.1016/S0300-483X(02)00378-5Search in Google Scholar

18. Mohan S, Kapoor A, Singgihi A, Zhang Z, Taylor T, Yu H, Chadwick RB, Chung YS, Donahue Lr, Rosen C, Crawford GC, Wergedal J, Baylink Dj. Spontaneous fractures in the mouse mutant sfx are caused by deletion of the gulonolactone oxidase gene, causing vitamin C defi ciency. J Bone Miner Res 2005;20:1597-610. doi: 10.1359/JBMR.05040610.1359/JBMR.05040616059632Search in Google Scholar

19. Hemmati AA, Nazari Z, Ranjbari N, Torfi A. Comparison of the preventive effect of vitamin C and E on hexavalent chromium induced pulmonary fibrosis in rat. Inflammopharmacology 2008;16:195-7. doi: 10.1007/ s10787-008-7004-410.1007/s10787-008-7004-418759078Search in Google Scholar

20. Wang XF, Lou XM, Shen Y, Xing mL, Xu LH. Apoptoticrelated protein changes induced by hexavalent chromium in mice liver. Environ Toxicol 2010;25:77-82. doi: 10.1002/ tox.20478Search in Google Scholar

21. Bour-Jr W, Hamm-Ming S, Yue-Liang G, Yu-Hsuan L, Ching- Shu L, Min-Hsiung P, Ying-Jan W. Hexavalent chromium induced ROS formation, Akt, NF-kappaB, and MAPK activation, and TNF-α and IL-1α production in keratinocytes. Toxicol Lett 2010;198:216-24. doi: 10.1016/ j.toxlet.2010.06.02410.1016/j.toxlet.2010.06.02420619327Search in Google Scholar

22. Samuel JB, Stanley JA, Roopha DP, Vengatesh G, Anbalagan J, Banu SK, Aruldhas MM. Lactational hexavalent chromium exposure-induced oxidative stress in rat uterus is associated with delayed puberty and impaired gonadotropin levels. Hum Exp Toxicol 2001;30:91-101. doi: 10.1177/096032711036463810.1177/096032711036463820203132Search in Google Scholar

23. Tajima H, Yoshida T, Ohnuma A, Fukuyama T, Hayashi K, Yamaguchi S, Ohtsuka R, Sasaki J, Tomita M, Kojima S, Takahashi N, Kashimoto Y, Kuwahara M, Takeda M, Kosaka T, Nakashima N, Harada T. Pulmonary injury and antioxidant response in mice exposed to arsenate and hexavalent chromium and their combination. Toxicology 2010;267:118-24. doi: 10.1016/j.tox.2009.10.03210.1016/j.tox.2009.10.03219895865Search in Google Scholar

24. Krumschnabel G, Nawaz M. Acute toxicity of hexavalent chromium in isolated teleost hepatocytes. Aquat Toxicol 2004;70:159-67. doi: 10.1016/j.aquatox.2004.09.00110.1016/j.aquatox.2004.09.00115522432Search in Google Scholar

25. Griselda RB, William EA, Kalyanaraman B, Judith MM, Charles RM. Reduction of hexavalent chromium by human cytochrome b5: generation of hydroxyl radical and superoxide. Free Radic Biol Med 2007;42:738-55. doi: 10.1016/j. freeradbiomed.2006.10.055Search in Google Scholar

26. O,Brien TJ, Ceryak S, Patierno SR. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutat Res 2003;533:3-36. doi: 10.1016/j.mrfmmm.2003.09.006 10.1016/j.mrfmmm.2003.09.00614643411Search in Google Scholar

Inglese, Slovenian
Frequenza di pubblicazione:
4 volte all'anno
Argomenti della rivista:
Medicina, Scienze medicali di base, altro